Genopole
NEWSLETTER
January, 2017
Partager Partager Partager Partager
Genopole
 
 
Happy new year 2017
 
  WHAT'S NEW AT GENOPOLE
 

Global Bioenergies et Syngip

Global Bioenergies plans to acquire Dutch start-up Syngip; gaseous carbon feedstocks for renewable isobutene process


Global Bioenergies, the developer of a process to convert renewable resources into light olefin hydrocarbons via fermentation (with an initial focus on isobutene), signed a contribution agreement with the shareholders of Syngip B.V. to transfer all Syngip shares to Global Bioenergies S.A.
 
Read more {...} Winners of #GYBA 2016
 
ENTREPRENEUR IS A FRENCH WORD

Here Comes the French Tech


Genopole has joined France's La French Tech network in Healthtech. La French Tech is a national initiative launched under the auspices of the Ministry of Economy to support and promote globally the French start-up ecosystem.

The aim is to bring together France's most dynamic clusters in different thematic fields (i.e., ITC, IOT, Sports, Cleantech, Fintech, Security, Retail, Foodtech, Entertainement).
La french tech
Read more {...} read more
 
NEWS FROM THE BIOCLUSTER COMPANIES
  Ynsect

Insect Breeding Innovator Ynsect Raises $15.2m to Help Build a Sustainable Global Food System


Ynsect - the global leader in the mass-scale breeding of insects for the animal feed markets - announced in December that it closed a $15.2m Series B round led by Future Positive Capital, Quadia SA and Bpifrance Ecotechnologies, with participation from existing investors Emertec, Demeter, Vis Vires New Protein Capital and Business Angels.
 
This latest round brings the cumulative amount Ynsect has raised, from private and public sources, to $37m over the last three years - the largest-ever investment in the sector. The announcement came as EU member states endorsed a European Commission proposal to allow the wider use of insect proteins in animal feed.
Read more {...} read more
 
REAL ESTATE

Biostart to Set Up Shop at Genopole


Thanks to Genopole's real estate offering, the winners of this year's edition of the Young Biotech Award will be able to set up shop at the Genopole cluster within a month of the competition.
Biostart, the overall winner, mainly visited the incubator building, perfectly adapted to the needs of start-ups with offices, P1 and P2 labs as well as shared equipment such as qPCR (quantitative Polymerase Chain Reaction) and HPLC (High performance liquid chromatography).
 
Biostart to set up shop at Genopole
Read more {...} read more
 
NETWORKING

Genopole at the 9th Annual Conference Biotech Showcase in San Francisco

Genopole was present at the 9th Annual Conference Biotech Showcase which took place in San Francisco.
With engaging presentations on the challenges facing biotechs today, investment opportunities and value creation, the conference was a great partnering opportunity for Genopole Entreprises.

Laurent Pépin, International Project Manager at Genopole had over 30 meetings with companies wishing to develop or deploy their activity in the Paris area as well as investment funds and decision makers wishing to know more about the Genopole biocluster.
Biotech Showcase @San Francisco
(Right to left: L. Pépin from Genopole, I. Pelletier-Bressac from IGR and G. Avenard from Acticor Biotech)
 
  UPCOMING
  Colloque Biologie et médecine du futur

Biologie et Médecine du Futur


On February 27th, Genopole is hosting an international colloquium dedicated to "Biology and The Medicine of the Future" in Paris focused on medicine and the biotechnologies dedicated to medicine.

Advances in human health have been marked by technological breakthroughs that pave the way for new applications.
Human genome sequencing led to precision medicine based on the sequencing of individual genomes. The advent of new sequencing robots combined with the Big data /Smart data duo has generalised access to reliable diagnostics and therapeutic solutions for patients.
Regenerative medicine is now offering new therapeutic solutions to correct genetic problems. Come and join us to discover how these advances are radically changing healthcare throughout the world from both a social and economic point of view and to discuss their ethical implications.
Read more {...} read more
 
  For additional information, write to international@genopole.fr
UK